Science Explorer Interactive view Map
Company · Boston · United States

Atea Pharmaceuticals (United States)

ateapharma.comROR OpenAlex
Research works
37
▲ 62% vs 2013–17
Citations
412
11.2 per fractional work
Top-10% rate
20.6%
record average 16.5%
Open access
55%
world 28%

Not ranked overall: Atea Pharmaceuticals (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.66× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.38× its world share, 1 worksBiochemistry, Geneti…Immunology and Microbiology: 8.08× its world share, 1 worksImmunology and Micro…Chemistry: 2.12× its world share, 0 worksChemistryMaterials Science: 0.32× its world share, 0 worksMaterials ScienceMedicine: 3.47× its world share, 7 worksMedicineNursing: 3.39× its world share, 0 worksNursingSocial Sciences: 0.26× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 8.1×. Every wedge is a field page.

Which keywords describe research at Atea Pharmaceuticals (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Epidemiology, Fermentation, Antioxidant Activity, Immune Response, Antioxidant, Antiretroviral Therapy, Aroma Compounds and Neurotransmitters.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Epidemiology6▲ 3.8×11 topics
  2. Fermentation4▲ 66×2 topics
  3. Antioxidant Activity3▲ 16×4 topics
  4. Immune Response3▲ 12×4 topics
  5. Oxidative Stress3▲ 4.1×7 topics
  6. Antioxidant3▲ 11×6 topics
  7. Antiretroviral Therapy3▲ 30×2 topics
  8. Aroma Compounds2▲ 76×2 topics
  9. Metabolism2▲ 9.9×3 topics
  10. Neurotransmitters2▲ 97×2 topics
  11. Cancer2▲ 4.5×5 topics
  12. Vaccine Development2▲ 20×3 topics
  13. Gamma-Aminobutyric Acid2▲ 228×1 topic
  14. Innate Immunity2▲ 17×4 topics
  15. Plant Responses2▲ 86×1 topic
  16. Vaccine2▲ 15×5 topics
  17. Enzyme Regulation2▲ 114×2 topics
  18. Drug Resistance2▲ 17×1 topic
  19. HIV Infection2▲ 44×1 topic
  20. Immunity2▲ 15×2 topics
  21. Nucleotide Metabolism2▲ 145×1 topic
  22. Purine Biosynthesis2▲ 145×1 topic
  23. Anti-inflammatory2▲ 17×3 topics
  24. Genetic Variation2▲ 16×2 topics
  25. Neuroprotective Effects2▲ 39×2 topics
  26. Hepatitis C Virus2▲ 86×1 topic
  27. Treatment2▲ 3.5×1 topic
  28. ACE2 Receptor2▲ 36×2 topics
  29. SARS-CoV-22▲ 29×2 topics
  30. Antigen Presentation1▲ 36×2 topics
  31. Korean Traditional Food1▲ 111×1 topic
  32. Quality Characteristics1▲ 80×1 topic
  33. Bee Venom1▲ 119×1 topic
  34. Coronavirus1▲ 28×1 topic
  35. Melittin1▲ 119×1 topic
  36. Neuroprotection1▲ 8.5×2 topics
  37. spike protein1▲ 74×1 topic
  38. Alzheimer's Disease1▲ 11×3 topics
  39. Carnosine1▲ 85×1 topic
  40. Health Benefits1▲ 10×2 topics

Which research topics does Atea Pharmaceuticals (United States) publish most on?

By volume in 2022–2025: SARS-CoV-2 and COVID-19 Research, Hepatitis C virus research, HIV/AIDS drug development and treatment and Mosquito-borne diseases and control.

SARS-CoV-2 and COVID-19 Research: 1 fractional worksHepatitis C virus research: 1 fractional worksHIV/AIDS drug development and treatment: 1 fractional worksMosquito-borne diseases and control: 1 fractional worksViral Infections and Vectors: 1 fractional worksMalaria Research and Con…0Malaria Research and Control: 0 fractional worksBiochemical and Molecular Research: 0 fractional worksvaccines and immunoinformatics approaches: 0 fractional worksImmunotherapy and Immune Responses: 0 fractional worksVaccine Coverage and Hesitancy: 0 fractional works
Infectious DiseasesHepatologyPublic Health, Environmental and Occupational HealthMolecular Biology2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 SARS-CoV-2 and COVID-19 Research Infectious Diseases 1 works
  2. 2 Hepatitis C virus research Hepatology 1 works
  3. 3 HIV/AIDS drug development and treatment Infectious Diseases 1 works
  4. 4 Mosquito-borne diseases and control Public Health, Environmental and Occupational Health 1 works
  5. 5 Viral Infections and Vectors Infectious Diseases 1 works
  6. 6 Malaria Research and Control Public Health, Environmental and Occupational Health 0 works
  7. 7 Biochemical and Molecular Research Molecular Biology 0 works
  8. 8 vaccines and immunoinformatics approaches Molecular Biology 0 works
  9. 9 Immunotherapy and Immune Responses Immunology 0 works
  10. 10 Vaccine Coverage and Hesitancy Health 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available54.8%not open45.2%

World: 28% of research is openly available.

with international co-authors25.0%domestic only75.0%

World: 19% is written across borders.

How has Atea Pharmaceuticals (United States)'s research output changed?

Output in 2018–2022 was 62% higher than in 2013–2017.

20002005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Boston

All research institutions in Boston

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.